Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Allied Health Professionals’ Corner
Author Reply
Book Review
Brief Communication
Case Report
Case Series
Clinical Case Report
Clinicopathological Conference
Commentary
Commentary : Patient’s Voice
Corrigendum
Editorial
Editorial – World Kidney Day 2016
Editorial Commentary
Erratum
Foreward
Guideline
Guidelines
Image in Nephrology
Images in Nephrology
In-depth Review
Letter to Editor
Letter to the Editor
Letter to the Editor – Authors’ reply
Letters to Editor
Literature Review
Nephrology in India
Notice of Retraction
Obituary
Original Article
Perspective
Research Letter
Retraction Notice
Review
Review Article
Short Review
Special Article
Special Feature
Special Feature - World Kidney Day
Systematic Review
Technical Note
Varia
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Allied Health Professionals’ Corner
Author Reply
Book Review
Brief Communication
Case Report
Case Series
Clinical Case Report
Clinicopathological Conference
Commentary
Commentary : Patient’s Voice
Corrigendum
Editorial
Editorial – World Kidney Day 2016
Editorial Commentary
Erratum
Foreward
Guideline
Guidelines
Image in Nephrology
Images in Nephrology
In-depth Review
Letter to Editor
Letter to the Editor
Letter to the Editor – Authors’ reply
Letters to Editor
Literature Review
Nephrology in India
Notice of Retraction
Obituary
Original Article
Perspective
Research Letter
Retraction Notice
Review
Review Article
Short Review
Special Article
Special Feature
Special Feature - World Kidney Day
Systematic Review
Technical Note
Varia
View/Download PDF

Translate this page into:

Letters to Editor
25 (
6
); 390-391
doi:
10.4103/0971-4065.161517

Hypovolemic hyponatremia after trimethoprim use

Department of Nephrology, SVIMS, Tirupati, Andhra Pradesh, India
Department of Neurology, SVIMS, Tirupati, Andhra Pradesh, India

Address for correspondence: Dr. Rapur Ram, Department of Nephrology, SVIMS, Tirupati, Andhra Pradesh, India. E-mail: Ram_5_1999@yahoo.com

Licence

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Disclaimer:
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.

Sir,

A 49-year-old deceased donor renal allograft recipient presented a year after transplantation with complaints of fatigue, nausea, and vomiting of 2 days duration. A week prior to presentation, he was diagnosed to have urinary tract infection with Escherichia coli and was prescribed tablet trimethoprim (20 mg/kg/day) -sulfamethoxazole (100 mg/kg/day) in two divided doses. At presentation, patient had sunken eyes, dry mouth, decreased skin turgor, tachycardia and postural hypotension. He was afebrile, normal respiratory and cardiovascular examination. Central nervous system examination showed no focal neurological deficit. Investigations showed serum creatinine 1.0 mg/dl, blood urea 64 mg/dl, serum sodium 115 mEq/L, potassium 5.6 mEq/L, uric acid 7.8 mg/dl, chloride 90 mEq/L, bicarbonate 17.3 mmol/L, and pH 7.36. The urinary sodium and potassium were 142 and 41 mEq/L respectively. The serum and urine osmolality 248 and 161 mOsm/kg respectively. The fractional excretion of sodium was <1%, uric acid: 6.19%, transtubular potassium gradient 3.01, serum thyroid stimulating hormone 0.5 µIU/L (0.17–4.05 µIU/mL) and serum cortisol 5.5 µg/dl (6.7–22.60 µg/dl). Ultrasound showed normal renal allograft and collapsed inferior vena cava. Trimethoprim-sulfamethoxazole combination was stopped. He was encouraged to consume high salt diet. With this, serum sodium increased to 127 mEq/L after 48 h and 135 mEq/L after 96 h.

Hypotonic hyponatremia can be divided according to volume status as hypovolemic, euvolemic, and hypervolemic. High urinary sodium excretion in patients of hypovolemia is inappropriate. It is possible in adrenal insufficiency, hypothyroidism, metabolic alkalosis, diuretic use, cerebral salt wasting, and salt wasting nephropathy.[1] Our patient had no feature suggestive of these etiologies. Trimethoprim-sulfamethoxazole can cause hyperkalemia, hyponatremia, and metabolic acidosis. Hyperkalemia is common than the others.[2]

Trimethoprim at high doses acts as reversible direct sodium channel inhibitor at the level of the eNaC in the distal tubule. It acts as a potassium sparing diuretic.[3] It also causes a distal acidification defect, with hyperkalemia contributing to reduced net acid excretion by inhibition of ammoniagenesis. However, there are reports of hyponatremia with the standard doses of trimethoprim.[4]

The diagnosis of trimethoprim induced hyponatremia depends on recognition of hypovolemia and elevated urinary sodium concentration. It has to be distinguished from syndrome of inappropriate anti diuretic hormone secretion (SIADH), the leading cause of hyponatremia in hospitalized patients[5] in whom fluid restriction is desired, while in trimethoprim induced hyponatremia liberal salt intake is the remedy.[6] Urine sodium excretion is elevated in both the conditions. SIADH is euvolemic condition while trimethoprim induced hyponatremia is hypovolemic condition. The latter, therefore, is associated with tachycardia, orthostatic hypotension, increased blood urea, increased rennin, aldosterone, and antidiuretic hormone.[1] The high antidiuretic hormone is also a feature of SIADH. However, SIADH is characterized by hypouricemia due to volume expansion resultant decrease in proximal tubular reabsorption of uric acid and hence elevated fractional excretion of uric acid (<10% suggestive of prerenal causes, >10% suggestive of SIADH or renal causes). For the same reason, SIADH patients also have high fractional excretion of sodium.[7]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Financial support and sponsorship Nil.

Conflicts of interest There are no conflicts of interest.

References

  1. , , , , , . Trimethoprim-associated hyponatremia. Am J Kidney Dis. 2013;62:1188-92.
    [Google Scholar]
  2. , , , , . Severe hyponatremia and hyperkalemia induced by trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia. Intern Med. 1995;34:96-9.
    [Google Scholar]
  3. , , , , , , . Brief report: trimethoprim-induced hyperkalemia in a patient with AIDS. N Engl J Med. 1993;328:703-6.
    [Google Scholar]
  4. , , , , , , . Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole. Intern Med. 2003;42:665-9.
    [Google Scholar]
  5. , , . Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356:2064-72.
    [Google Scholar]
  6. , , , , . Diuretic-induced hyponatremia. Ann Intern Med. 1971;75:853-63.
    [Google Scholar]
  7. , . Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab. 2003;14:182-7.
    [Google Scholar]
Show Sections